Domar (Pinazepam) is a moderate anxiolytic. The pharmacological activities of Domar are characterized by a marked anxiolytic effect acting on the limbic system, amygdala, and especially the hippocampus, exerting a specific and selective action on emotional control. It has a good muscle relaxant effect without any depressant action on the spinal cord. Domar also has an excellent anti-convulsant effect. The therapeutic index of Domar is high and its therapeutic effects appear fast and are long lasting. Research into the pharmacokinetics of Domar in man has shown that it has a half-life of about 12 hours. This offers decisive therapeutic advantages as the patient enjoys life free from drowsiness with one capsule twice daily.